[HTML][HTML] Nomogram based on monocyte-to-lymphocyte ratio to predict survival of unresectable esophageal squamous cell carcinoma who receive first-line PD-1/PD …
X Ma, Y Ding, J Qian, M Wan, N Li, C Mao, C Xiao… - Current …, 2022 - mdpi.com
Background. Chemoimmunotherapy has become the first-line treatment for unresectable
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
[HTML][HTML] Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD …
X Ma, Y Ding, J Qian, M Wan, N Li, C Mao… - Current …, 2022 - ncbi.nlm.nih.gov
Background. Chemoimmunotherapy has become the first-line treatment for unresectable
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
[PDF][PDF] Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1 …
X Ma, Y Ding, J Qian, M Wan, N Li, C Mao, C Xiao… - Curr … - pdfs.semanticscholar.org
Background. Chemoimmunotherapy has become the first-line treatment for unresectable
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 …
X Ma, Y Ding, J Qian, M Wan, N Li, C Mao… - Current Oncology …, 2022 - europepmc.org
Background Chemoimmunotherapy has become the first-line treatment for unresectable
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 …
X Ma, Y Ding, J Qian, M Wan, N Li… - Current oncology …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Chemoimmunotherapy has become the first-line treatment for unresectable
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 …
X Ma, Y Ding, J Qian, M Wan, N Li, C Mao… - Current Oncology …, 2022 - europepmc.org
Background Chemoimmunotherapy has become the first-line treatment for unresectable
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …